Low-Intensity Pulsed Ultrasound
- LOW-INTENSITY PULSED ULTRASOUND (LIPUS) is a NON-INVASIVE, low-risk device that delivers low-intensity pulsed acoustic energy to a fracture, typically applied for about 20 minutes DAILY by the patient at HOME, with the aim of promoting or accelerating bone healing; it has been used both in fresh fractures (to stimulate the stages of healing) and in delayed/non-unions.
- The proposed MECHANISM is MECHANOTRANSDUCTION - the micromechanical acoustic stimulus is sensed by bone-forming and other cells and stimulates the repair process at the MOLECULAR LEVEL across the stages of healing (modulating inflammation, chondrogenesis and endochondral ossification, gene/protein expression, angiogenesis and mineralisation).
- LIPUS is a LOW-RISK intervention: the only side effect reported is minor SKIN reactions in a small number of patients; it is non-invasive, used independently at HOME, and AVOIDS the disadvantages of surgery - re-hospitalisation, anaesthetic and operative complications, post-operative infection and thromboembolism - which is its main attraction.
- The EVIDENCE is the crux of the topic and must be framed honestly: while early and registry data and many case reports are encouraging, high-quality randomised trials and meta-analyses have shown INCONSISTENT or limited benefit for ACUTE/fresh fracture healing (leading some bodies to recommend against routine use for fresh fractures), whereas the rationale and interest are STRONGEST in DELAYED UNION and NON-UNION - where it offers a non-invasive option - with definitive non-inferiority trials versus surgery ongoing.
- For ESTABLISHED NON-UNION, SURGICAL revision remains the GOLD STANDARD treatment, but it carries the disadvantages of re-hospitalisation, anaesthesia and operative complications; LIPUS is positioned as a low-risk NON-INVASIVE alternative or adjunct that the patient can self-administer, and trials (e.g. non-inferiority studies of LIPUS versus surgery for non-union) aim to define whether it can substitute for surgery in selected cases.
- PRACTICALLY, LIPUS is reasonable to consider as a low-risk ADJUNCT in delayed/non-union and in high-risk fractures, set against an honest discussion of the inconsistent evidence and the fact that it is not a substitute for sound fracture management (stability, alignment, treating infection and addressing biological/host factors); non-union remains MULTIFACTORIAL and management must address the underlying cause, not rely on a device alone.
- “LIPUS = non-invasive, low-risk daily (~20 min) home-applied low-intensity pulsed ultrasound to promote bone healing. Proposed mechanism = MECHANOTRANSDUCTION stimulating repair at the molecular level.
- “Evidence (be honest): INCONSISTENT/limited benefit for FRESH fractures in high-quality trials; rationale STRONGEST in DELAYED UNION/NON-UNION; definitive non-inferiority-vs-surgery trials ongoing.
- “Surgical revision remains the GOLD STANDARD for established non-union; LIPUS is a low-risk non-invasive adjunct/alternative. Non-union is multifactorial - address the cause (stability, alignment, infection, host); don't rely on a device alone.
A non-invasive, low-risk (skin reactions only), home-applied daily device to promote bone healing - avoiding re-hospitalisation, anaesthesia and operative complications.
High-quality trials show inconsistent/limited benefit in fresh fractures; rationale is strongest in delayed/non-union. Surgery remains the gold standard for established non-union (trials ongoing).
What It Is & How It Is Thought to Work
LIPUS delivers low-intensity pulsed acoustic energy to a fracture, applied for about 20 minutes daily by the patient at home, to promote bone healing. The proposed mechanism is mechanotransduction: the micromechanical stimulus is sensed by bone cells and stimulates repair at the molecular level across the stages of healing (inflammation, chondrogenesis/endochondral ossification, gene/protein expression, angiogenesis and mineralisation). Its appeal is being low-risk (only minor skin reactions reported), non-invasive and self-administered, avoiding the re-hospitalisation, anaesthesia and operative complications of surgery.
Evidence & Place in Practice
- Fresh fractures: high-quality randomised trials/meta-analyses show inconsistent or limited benefit for acute fracture healing - it is not established as routinely beneficial for fresh fractures.
- Delayed union/non-union: the rationale and interest are strongest here, where LIPUS offers a non-invasive option; encouraging case reports and ongoing non-inferiority trials (LIPUS vs surgery) aim to define its role.
- Gold standard for non-union: surgical revision remains the standard, with its known disadvantages (re-hospitalisation, anaesthesia, complications) - LIPUS is a low-risk alternative/adjunct.
- Don't rely on a device alone: non-union is multifactorial - address stability, alignment, infection and host/biological factors; LIPUS supplements, not replaces, sound fracture management.
The balanced position on LIPUS is that it is a genuinely low-risk, non-invasive, patient-administered device whose appeal is avoiding the morbidity of surgery, but whose evidence base is mixed. High-quality trials have not consistently shown benefit for fresh fracture healing, so it should not be promoted as routinely accelerating ordinary fracture union; the stronger rationale is in delayed union and non-union, where a non-invasive option is attractive and where non-inferiority trials against surgery are underway. Crucially, non-union is multifactorial, and the device must not be used as a substitute for sound fracture management: mechanical stability and alignment must be adequate, infection must be excluded and treated, and host and biological factors (smoking, diabetes, vascularity, metabolic bone disease) must be addressed. Surgical revision remains the gold standard for an established non-union, and LIPUS is best framed to the patient as a low-risk adjunct or, in selected cases, an alternative - with an honest account of the inconsistent evidence.
Evidence & Key Studies
LIPUS versus surgery for non-union (PiNGUin) - non-inferiority RCT protocol
- Non-unions (fractures not healed after at least 6 months) occur in 2-10% of all fractures and up to 30% of patients with certain risk factors, with high treatment costs, pain and loss of function; surgical revision is the current gold standard but carries re-hospitalisation, secondary disease and operative side effects.
- LIPUS is a low-risk procedure (skin reactions the only side effect in a very small number of patients) that patients can use independently at home, eliminating repeated hospital visits.
- The trial is designed to test whether daily LIPUS (20 minutes for 200 days) is non-inferior to surgical intervention for healing of upper- or lower-extremity non-unions - reflecting that LIPUS is a potential non-invasive alternative to surgery pending definitive evidence.
LIPUS for paediatric fracture non-union - a case report
- LIPUS is a conservative option used both in fresh fractures (to stimulate the stages of healing) and in non-unions, working by promoting repair at the molecular level.
- A child's distal-third humeral shaft atrophic non-union treated with LIPUS showed encouraging signs of union at 3 months and successful union at 6 months.
- While LIPUS is well studied in adult non-unions, evidence in children is limited; this case supports further trials of LIPUS for paediatric non-union (single case report - low-level evidence).
According to PubMed, the epidemiology of non-union (2-10% of fractures, up to 30% with risk factors), the status of surgical revision as the current gold standard with its disadvantages, the low-risk home-use profile of LIPUS (skin reactions the only side effect), and the framing of LIPUS as a potential non-invasive alternative whose non-inferiority to surgery is being tested come from the cited Steinhausen (PiNGUin) trial protocol; the conservative use of LIPUS in fresh fractures and non-unions and an example of successful union in paediatric non-union from the cited Basa case report. The proposed mechanotransduction mechanism, the inconsistent high-quality-trial evidence for fresh fractures, and the principle that non-union is multifactorial (requiring attention to stability/alignment/infection/host factors) are standard, well-established teaching. (See also our Fracture Healing, Non-Union/Delayed Union and Bone Stimulators (Electrical/Electromagnetic) topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A patient with a tibial non-union asks about low-intensity pulsed ultrasound. How do you counsel them?”
Mnemonics & Memory Aids
LIPUS
Hook:LIPUS: Low-intensity pulsed ultrasound, Inconsistent in fresh #, Promotes repair (mechanotransduction), Use in delayed/non-Union, Surgery still gold standard.
What it is
- Low-intensity pulsed ultrasound - non-invasive device
- ~20 min daily, self-applied at home
- Used in fresh fractures and delayed/non-unions
Mechanism & risk
- Proposed mechanotransduction -> repair at molecular level (across healing stages)
- Low-risk: minor skin reactions the only reported side effect
- Avoids re-hospitalisation/anaesthesia/operative complications
Evidence
- Inconsistent/limited benefit for fresh fractures (high-quality trials)
- Rationale strongest in delayed union/non-union
- Non-inferiority trials vs surgery ongoing (non-union 2-10%, up to 30% with risk factors)
Place in practice
- Surgical revision = gold standard for established non-union
- LIPUS = low-risk non-invasive adjunct/alternative
- Non-union is multifactorial - address stability/alignment/infection/host; not a substitute